Med. praxi. 2012;9(5):238-242

Panic disorder

MUDr.Petr Šilhán1, prof.MUDr.Ján Pavlov Praško, CSc.2,3, MUDr.Dana Kamarádová2,3, MUDr.et Bc.Aleš Grambal2,3, PhDr.Tomáš Diveky2,3
1 Oddělení psychiatrické FN Ostrava
2 Klinika psychiatrie LF UP v Olomouci
3 Klinika psychiatrie FN Olomouc

Panic disorder is a common disease characterised by recurrent massive attacks of sudden anxiety, accompanied by various somatic symptoms

and fearful thoughts. Panic disorder can have both acute and chronic course and may be associated with reduction in quality of life.

Although there are many neurobiological and psychological hypotheses, there are still many questions to be answered. Anxiolytics can be

useful for short-therm treatment, for long-term treatment we use SSRI. At least equeal effect proved cognitive behavioural therapy.

Keywords: panic disorder, Serotonin, Amygdala, SSRI, Cognitive Behavioural Therapy

Published: May 31, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šilhán P, Pavlov Praško J, Kamarádová D, Grambal A, Diveky T. Panic disorder. Med. praxi. 2012;9(5):238-242.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kessler R, Chiu WT, Jin R, et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006; 63(4): 415-424. Go to original source... Go to PubMed...
    2. Hettema JM, Neale MC, Kendler KS. A review and metaanalysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001; 158: 1568-1578. Go to original source... Go to PubMed...
    3. Hettema JM, Prescott CA, Myers JM, et al. The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 2005; 62: 182-189. Go to original source... Go to PubMed...
    4. Bakker A, van Balkom AJLM, Stein DJ. Evidence-based pharmacotherapy of panic disorder. International Journal of Neuropsychopharmacology 2005; 8: 473-482. Go to original source... Go to PubMed...
    5. Graeff FG. On serotonin and experimental anxiety. Psychopharmacology 2002; 163: 467-476. Go to original source... Go to PubMed...
    6. Gorman JM, Kent JM, Sullivan GM, et al. Neuroanatomical Hypothesis of Panic Disorder, Revised. Am J Psychiatry 2000; 157: 493-505. Go to original source... Go to PubMed...
    7. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000; 12(Suppl 1): 2-19. Go to original source... Go to PubMed...
    8. Klein DF. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry 1993; 50: 306-317. Go to original source... Go to PubMed...
    9. Praško J, Záleský R, Houbová P. Panická porucha. In: Praško J, Možný P, Šlepecký M, a kol. Kognitivně behaviorální terapie psychických poruch. TRITON Praha/Kroměříž 2007: 398-439.
    10. De Masi F. The psychodynamic of panic attacks: A useful integration of psychoanalysis and neuroscience. Int J Psychoanal 2004; 85: 311-336. Go to original source... Go to PubMed...
    11. Slaap BA, den Boer JA. The prediction of nonresponse to pharmacotherapy in panic disorder: A review. Depression and Anxiety 2001; 14: 112-122. Go to original source... Go to PubMed...
    12. Barlow DH, Gorman JM, Shear K, et al. Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder. JAMA 2000; 283(19): 2529-2536. Go to original source... Go to PubMed...
    13. Praško J, Kamarádová D, Jelenová D, et al. Panická porucha v průběhu života. Postgraduální medicína 2012; 14: 44-50.
    14. Praško J, Látalová K, Kamarádová D, et al. Panická porucha. Practicus 2011; 9: 11-17.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.